📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

243.0 mL/min

Highly Dialyzable

Significant removal expected. Half-life: 3 days. Consider post-dialysis supplementation.

Data Used:
✅ protein_binding, molar_mass, mw_factor, vd, vd_factor, half_life

Free fraction: 0.75 Mw factor: 1 Vd factor: 1 Hl factor: 1.2 Half life: 3 days Half life category: Extended (> 72h)

🫀

4.8 mL/min

Low PD Clearance

Minimal removal expected. No supplementation needed. Half-life: 3 days.

Data Used:
✅ protein_binding, molar_mass, half_life

Free fraction: 0.75 Half life: 3 days Half life category: Extended (> 72h)

🔄

Moderate Risk

This drug may be removed by TPE. Long half-life may increase significance. Consider monitoring.

Data Used:
✅ protein_binding, vd, half_life

Half life: 3 days Half life category: Extended (> 72h)

🧪

Moderate Effectiveness

Some removal possible. Long half-life may justify use in severe overdose.

Data Used:
✅ vd, half_life

Half life: 3 days Half life category: Extended (> 72h)

Modality	Clearance/Value	Half-Life	Classification	Data Quality
Hemodialysis	243.0 mL/min	3 days	Highly Dialyzable	Complete Data
Peritoneal Dialysis	4.8 mL/min	3 days	Low PD Clearance	Complete Data
Plasmapheresis (TPE)	Moderate Risk	3 days	N/A	Complete Data
Hemoadsorption	Moderate Effectiveness	3 days	N/A	Complete Data

Hemodialysis: Estimates based on high-flux dialyzer (urea clearance 270 mL/min), Qb 300 mL/min, 4-hour session.
Peritoneal Dialysis: Estimates based on CAPD (Continuous Ambulatory Peritoneal Dialysis).
TPE: Risk assessment based on protein binding and volume of distribution.
Hemoadsorption: Effectiveness based on volume of distribution. Most effective for drugs with Vd < 0.2 L/kg.
Data Quality: Estimates with missing data use default assumptions. Consider adding missing data for more accurate predictions.
Clinical Note: These are descriptive estimates only. Always consult clinical guidelines and monitor drug levels when available.